Tag: non-genomic actions

3,5-Diiodothyronine: A Novel Thyroid Hormone Metabolite and Potent Modulator of Energy Metabolism

This review explores the metabolic effects of 3,5-diiodo-L-thyronine (3,5-T2), an endogenous thyroid hormone metabolite. In rodent models, exogenous 3,5-T2 administration rapidly increases resting metabolic rate and induces beneficial hypolipidemic effects. The mechanisms are primarily non-genomic, targeting mitochondria to enhance oxidative phosphorylation and fatty acid oxidation. While some thyroid hormone receptor-mediated

Read More »

Novel Actions of Progesterone: What We Know Today and What Will Be the Scenario in the Future?

This 2012 review highlights emerging non-reproductive roles of progesterone, including potential therapeutic applications in traumatic brain injury (TBI), stroke, Alzheimer’s disease, diabetic neuropathy, and crush injuries. Preclinical and early clinical studies suggest that progesterone and its derivatives, such as norethisterone and megestrol acetate, may offer neuroprotective and anti-inflammatory benefits. Additionally,

Read More »